Author Affiliations: School of Medicine (Dr Mendelson), Center for Bioethics (Drs Mendelson, Caplan, and Kirkpatrick), and Cardiovascular Medicine Division, Department of Medicine (Dr Kirkpatrick), University of Pennsylvania, Philadelphia; Division of Rheumatology, Department of Medicine, Thomas Jefferson University, Philadelphia (Dr Meltzer); and Mongan Institute for Health Policy, Massachusetts General Hospital, Harvard Medical School, Boston (Dr Campbell).
We applaud the attention the ACC and AHA give to conflicts of interest (COI). Few other organizations have been as forthcoming in addressing COI in the guidelines process. We agree with Drs Brindis and Sacco that the advent, publication, and acceptance of guidelines improve patient care, and the impetus for our research1 was not to deter guideline use.
Mendelson T, Meltzer M, Campbell EG, Caplan AL, Kirkpatrick JN. The Proactive Management of “Relationship With Industry” by ACC/AHA in the Creation of Our Cardiovascular Clinical Practice Guidelines—Reply. Arch Intern Med. 2011;171(17):1598–1600. doi:10.1001/archinternmed.2011.426